Header
For Healthcare Professionals

Initiate Jardiance Met® early for type 2 diabetes patients
like Navya or Pratham for its multiple benefits and proven protection*1,2

ico_Placehoder
ico_Placehoder

  1. Jardiance Met® India prescribing information dated April 2025.

  2. Zinman B, Wanner C, Lachin JM, et al; EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128.

  • *
    Adult patients with insufficiently controlled type 2 diabetes and CAD, PAD, or a history of MI or stroke.1,2 
  • †
    Navya is not an actual patient.
  • BMI, body mass index; CAD, coronary artery disease; HbA1c, hemoglobin A1c; mg, milligram; MI, myocardial infarction; PAD, peripheral artery disease; T2D, type 2 diabetes; T2DM, type 2 diabetes mellitus.

Initiate Jardiance Met® early for type 2 diabetes patients
like Pratham for its multiple benefits and proven protection1,2*

ico_Placehoder
ico_Placehoder

  1. Jardiance Met® India prescribing information dated April 2025.

  2. Zinman B, Wanner C, Lachin JM, et al; EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128.

  • *
    Adult patients with insufficiently controlled type 2 diabetes and CAD, PAD, or a history of MI or stroke.1,2
  • †
    Pratham is not an actual patient.
  • BMI, body mass index; CAD, coronary artery disease; dL, deciliter; HbA1c, hemoglobin A1c; mg, milligram; MI, myocardial infarction; PAD, peripheral artery disease; T2D, type 2 diabetes; T2DM, type 2 diabetes mellitus.